199 related articles for article (PubMed ID: 26004218)
1. A drug carrier targeting murine uPAR for photodynamic therapy and tumor imaging.
Zhou X; Zheng K; Li R; Chen Z; Yuan C; Hu P; Chen J; Xue J; Huang M
Acta Biomater; 2015 Sep; 23():116-126. PubMed ID: 26004218
[TBL] [Abstract][Full Text] [Related]
2. A novel tumor targeting drug carrier for optical imaging and therapy.
Li R; Zheng K; Hu P; Chen Z; Zhou S; Chen J; Yuan C; Chen S; Zheng W; Ma E; Zhang F; Xue J; Chen X; Huang M
Theranostics; 2014; 4(6):642-59. PubMed ID: 24723985
[TBL] [Abstract][Full Text] [Related]
3. Zinc phthalocyanine conjugated with the amino-terminal fragment of urokinase for tumor-targeting photodynamic therapy.
Chen Z; Xu P; Chen J; Chen H; Hu P; Chen X; Lin L; Huang Y; Zheng K; Zhou S; Li R; Chen S; Liu J; Xue J; Huang M
Acta Biomater; 2014 Oct; 10(10):4257-68. PubMed ID: 24969665
[TBL] [Abstract][Full Text] [Related]
4. Nafamostat Mesylate in Combination with the Mouse Amino-Terminal Fragment of Urokinase-Human Serum Albumin Improves the Treatment Outcome of Triple-Negative Breast Cancer Therapy.
Zhou Y; Yu S; Chen D; Li H; Xu P; Yuan C; Jiang L; Huang M
Mol Pharm; 2023 Feb; 20(2):905-917. PubMed ID: 36463525
[TBL] [Abstract][Full Text] [Related]
5. Amino-terminal fragment of urokinase inhibits tumor cell invasion in vitro and in vivo: respective contribution of the urokinase plasminogen activator receptor-dependent or -independent pathway.
Li H; Soria C; Griscelli F; Opolon P; Soria J; Yeh P; Legrand C; Vannier JP; Belin D; Perricaudet M; Lu H
Hum Gene Ther; 2005 Oct; 16(10):1157-67. PubMed ID: 16218777
[TBL] [Abstract][Full Text] [Related]
6. Albumin-based drug carrier targeting urokinase receptor for cancer therapy.
Li H; Wang Z; Yu S; Chen S; Zhou Y; Qu Y; Xu P; Jiang L; Yuan C; Huang M
Int J Pharm; 2023 Mar; 634():122636. PubMed ID: 36696930
[TBL] [Abstract][Full Text] [Related]
7. Nanoparticle Binding to Urokinase Receptor on Cancer Cell Surface Triggers Nanoparticle Disintegration and Cargo Release.
Li S; Yuan C; Chen J; Chen D; Chen Z; Chen W; Yan S; Hu P; Xue J; Li R; Zheng K; Huang M
Theranostics; 2019; 9(3):884-899. PubMed ID: 30809315
[TBL] [Abstract][Full Text] [Related]
8. DOT corrected fluorescence molecular tomography using targeted contrast agents for small animal tumor imaging.
Tan Y; Cao Z; Sajja HK; Lipowska M; Wang YA; Yang L; Jiang H
J Xray Sci Technol; 2013; 21(1):43-52. PubMed ID: 23507851
[TBL] [Abstract][Full Text] [Related]
9. Tetra-triethyleneoxysulfonyl substituted zinc phthalocyanine for photodynamic cancer therapy.
Kuzyniak W; Ermilov EA; Atilla D; Gürek AG; Nitzsche B; Derkow K; Hoffmann B; Steinemann G; Ahsen V; Höpfner M
Photodiagnosis Photodyn Ther; 2016 Mar; 13():148-157. PubMed ID: 26162500
[TBL] [Abstract][Full Text] [Related]
10. Tumor Targeting Chemo- and Photodynamic Therapy Packaged in Albumin for Enhanced Anti-Tumor Efficacy.
Zheng K; Liu H; Liu X; Wang Y; Li L; Li S; Xue J; Huang M
Int J Nanomedicine; 2020; 15():151-167. PubMed ID: 32021171
[TBL] [Abstract][Full Text] [Related]
11. Methylsulfonyl Zn phthalocyanine: A polyvalent and powerful hydrophobic photosensitizer with a wide spectrum of photodynamic applications.
İşci Ü; Beyreis M; Tortik N; Topal SZ; Glueck M; Ahsen V; Dumoulin F; Kiesslich T; Plaetzer K
Photodiagnosis Photodyn Ther; 2016 Mar; 13():40-47. PubMed ID: 26529064
[TBL] [Abstract][Full Text] [Related]
12. Photosensitizer enhanced disassembly of amphiphilic micelle for ROS-response targeted tumor therapy in vivo.
Dai L; Yu Y; Luo Z; Li M; Chen W; Shen X; Chen F; Sun Q; Zhang Q; Gu H; Cai K
Biomaterials; 2016 Oct; 104():1-17. PubMed ID: 27423095
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic therapy: tumor targeting with adenoviral proteins.
Allen CM; Sharman WM; La Madeleine C; Weber JM; Langlois R; Ouellet R; van Lier JE
Photochem Photobiol; 1999 Oct; 70(4):512-23. PubMed ID: 10546549
[TBL] [Abstract][Full Text] [Related]
14. Near-Infrared Activatable Phthalocyanine-Poly-L-Glutamic Acid Conjugate: Enhanced in Vivo Safety and Antitumor Efficacy toward an Effective Photodynamic Cancer Therapy.
Cheah HY; Gallon E; Dumoulin F; Hoe SZ; Japundžić-Žigon N; Glumac S; Lee HB; Anand P; Chung LY; Vicent MJ; Kiew LV
Mol Pharm; 2018 Jul; 15(7):2594-2605. PubMed ID: 29763568
[TBL] [Abstract][Full Text] [Related]
15. Dual actions of albumin packaging and tumor targeting enhance the antitumor efficacy and reduce the cardiotoxicity of doxorubicin in vivo.
Zheng K; Li R; Zhou X; Hu P; Zhang Y; Huang Y; Chen Z; Huang M
Int J Nanomedicine; 2015; 10():5327-42. PubMed ID: 26346331
[TBL] [Abstract][Full Text] [Related]
16. In vitro photodynamic activities of zinc(II) phthalocyanines substituted with pyridine moieties.
Liu JY; Li J; Yuan X; Wang WM; Xue JP
Photodiagnosis Photodyn Ther; 2016 Mar; 13():341-343. PubMed ID: 26192694
[No Abstract] [Full Text] [Related]
17. Murine monoclonal antibodies against murine uPA receptor produced in gene-deficient mice: inhibitory effects on receptor-mediated uPA activity in vitro and in vivo.
Pass J; Jögi A; Lund IK; Rønø B; Rasch MG; Gårdsvoll H; Lund LR; Ploug M; Rømer J; Danø K; Høyer-Hansen G
Thromb Haemost; 2007 Jun; 97(6):1013-22. PubMed ID: 17549305
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus-mediated gene transfer of urokinase plasminogen inhibitor inhibits angiogenesis in experimental arthritis.
Apparailly F; Bouquet C; Millet V; Noel D; Jacquet C; Opolon P; Perricaudet M; Sany J; Yeh P; Jorgensen C
Gene Ther; 2002 Feb; 9(3):192-200. PubMed ID: 11859422
[TBL] [Abstract][Full Text] [Related]
19. Dual-targeting nanosystem for enhancing photodynamic therapy efficiency.
Xu J; Zeng F; Wu H; Yu C; Wu S
ACS Appl Mater Interfaces; 2015 May; 7(17):9287-96. PubMed ID: 25876183
[TBL] [Abstract][Full Text] [Related]
20. [Molecular Image of Superparamagnetic Iron Oxide Nanopariticle Labeled with hATF in Colon Tumor Models].
Zhang S; Wang L; Chen L; Xu H; Wu Q; Bi F; Gao F; Xu F
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2015 Oct; 32(5):1067-74. PubMed ID: 26964313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
